SHZ · 002412.SZ
Hunan Hansen Pharmaceutical Co., Ltd.
CN¥7.48+CN¥0.03 (+0.4%)
Hunan Hansen Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.43% below the high.
Loading market information…
SHH · 600594.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Guizhou Yibai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.47% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Guizhou Yibai Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.26 per share, paid semi-annual. The forward yield is 8.15% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Guizhou Yibai Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Guizhou Yibai Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise that encompasses the full spectrum of activities from researching and developing new drugs to their production and commercialization throughout the country. The company offers a diverse portfolio of medications, available in various dosage forms including capsules, tablets, granules, syrups, liquid injectables (small-volume), lyophilized powder injections, traditional pills, and oral solutions. These therapeutic agents are designed to address a broad range of medical conditions, specifically targeting oncology, cerebrovascular health, respiratory ailments, rheumatic diseases, digestive disorders, pediatric and gynecological illnesses, alongside providing anti-infective, anti-inflammatory, and pain management solutions. Established in 1995, the company maintains its headquarters in Guiyang, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥7.48+CN¥0.03 (+0.4%)
Hunan Hansen Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.43% below the high.
CN¥5.82+CN¥0.02 (+0.34%)
Shandong Wohua Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.29% below the high.
CN¥7.80-CN¥0.42 (-5.11%)
Hainan Shuangcheng Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.25% below the high.
CN¥5.04-CN¥0.26 (-4.91%)
PKU HealthCare Corp.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.92% below the high.
CN¥4.72-CN¥0.11 (-2.28%)
Baotou Dongbao Bio-Tech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 30.79% below the high.
CN¥6.50+CN¥0.18 (+2.85%)
Jiangxi Synergy Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.97% below the high.
CN¥11.33-CN¥0.05 (-0.44%)
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.9% below the high.
CN¥19.41-CN¥0.09 (-0.46%)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.15% below the high.
